Plasma carotene and α-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA)2

https://doi.org/10.1093/ajcn/82.4.879Get rights and content
Under an Elsevier user license
open archive

ABSTRACT

Background: Only a few observational studies have related plasma carotene and α-tocopherol to mortality in elderly subjects.

Objective: The objective was to study the association of plasma carotene (α-and β-carotene) and α-tocopherol with all-cause and cause-specific mortality in elderly subjects who participated in a European prospective study.

Design: Plasma concentrations of carotene and α-tocopherol were measured in 1168 elderly men and women. After a follow-up period of 10 y, 388 persons had died. The association between plasma antioxidants and mortality was analyzed by using Cox proportional hazard models. To put our results in context, we performed a meta-analysis of 5 studies on plasma antioxidants and all-cause mortality in elderly populations.

Results: Plasma carotene concentrations were associated with a lower mortality risk [adjusted rate ratio (RR) for an increment of 0.39 μmol/L: 0.79; 95% CI: 0.70, 0.89]. This lower mortality risk was observed for both cancer (RR: 0.59; 95% CI: 0.44, 0.79) and cardiovascular disease (RR: 0.83; 95% CI: 0.70, 1.00). The lower risk of cardiovascular death was confined to those with a body mass index (in kg/m2) <25 (RR: 0.67; 95% CI: 0.49, 0.94). Plasma concentrations of α-tocopherol were not associated with all-cause or cause-specific mortality. The results for both plasma antioxidants and all-cause mortality were confirmed by the meta-analysis.

Conclusions: This prospective study suggests that high plasma concentrations of carotene are associated both with lower mortality from all causes and with cancer in the elderly. For cardiovascular mortality, the inverse association was confined to elderly with body mass indexes <25.

Keywords:

Antioxidants
carotene
α-tocopherol
elderly
mortality
cancer
cardiovascular disease
cohort study

Cited by (0)

2

The SENECA study is supported by the European Union.